Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2005 1
2006 1
2008 1
2009 1
2010 4
2011 2
2012 3
2013 4
2014 3
2015 4
2016 4
2017 3
2018 9
2019 11
2020 17
2021 19
2022 14
2023 24
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

106 results

Results by year

Filters applied: . Clear all
Page 1
Treatment of Psoriasis Patients with Latent Tuberculosis Using IL-17 and IL-23 Inhibitors: A Retrospective, Multinational, Multicentre Study.
Torres T, Chiricozzi A, Puig L, Lé AM, Marzano AV, Dapavo P, Dauden E, Carrascosa JM, Lazaridou E, Duarte G, Carvalho AVE, Romiti R, Rompoti N, Teixeira L, Abreu M, Ippoliti E, Maronese CA, Llamas-Velasco M, Vilarrasa E, Del Alcázar E, Daponte AI, Papoutsaki M, Carugno A, Bellinato F, Gisondi P. Torres T, et al. Among authors: puig l. Am J Clin Dermatol. 2024 Mar;25(2):333-342. doi: 10.1007/s40257-024-00845-4. Epub 2024 Jan 24. Am J Clin Dermatol. 2024. PMID: 38265746 Free PMC article.
Price variability of TNF-α inhibitor biosimilars among European countries.
Geat D, Gisondi P, Maurelli M, Puig L, Paul C, Thaçi D, Iversen L, Bellinato F, Girolomoni G. Geat D, et al. Among authors: puig l. J Eur Acad Dermatol Venereol. 2023 Dec 18. doi: 10.1111/jdv.19756. Online ahead of print. J Eur Acad Dermatol Venereol. 2023. PMID: 38108512 No abstract available.
Corrigendum: The paradigm of IL-23-independent production of IL-17F and IL-17A and their role in chronic inflammatory diseases.
Navarro-Compán V, Puig L, Vidal S, Ramírez J, Llamas-Velasco M, Fernández-Carballido C, Almodóvar R, Pinto JA, Galíndez-Aguirregoikoa E, Zarco P, Joven B, Gratacós J, Juanola X, Blanco R, Arias-Santiago S, Sanz JS, Queiro R, Cañete JD. Navarro-Compán V, et al. Among authors: puig l. Front Immunol. 2023 Nov 22;14:1332177. doi: 10.3389/fimmu.2023.1332177. eCollection 2023. Front Immunol. 2023. PMID: 38077344 Free PMC article.
The journey of patients with skin diseases from the first consultation to the diagnosis in a representative sample of the European general population from the EADV burden of skin diseases study.
Richard MA, Paul C, Nijsten T, Gisondi P, Salavastru C, Taieb C, Stratigos A, Trakatelli M, Puig L; EADV Burden of Skin Diseases Project Team. Richard MA, et al. Among authors: puig l. J Eur Acad Dermatol Venereol. 2023 Oct;37 Suppl 7:17-24. doi: 10.1111/jdv.18916. J Eur Acad Dermatol Venereol. 2023. PMID: 37806003
Public perception of dermatologists in Europe: Results from a population-based survey.
Richard MA, Paul C, Nijsten T, Gisondi P, Salavastru C, Taieb C, Trakatelli M, Puig L, Stratigos A; EADV burden of skin diseases project team. Richard MA, et al. Among authors: puig l. J Eur Acad Dermatol Venereol. 2023 Oct;37 Suppl 7:27-37. doi: 10.1111/jdv.18988. J Eur Acad Dermatol Venereol. 2023. PMID: 37806001
Guselkumab-Treated Patients with Plaque Psoriasis Who Achieved Complete Skin Clearance for ≥ 156 Consecutive Weeks: A Post-Hoc Analysis From the VOYAGE 1 Clinical Trial.
Puig L, Costanzo A, de Jong EMGJ, Torres T, Warren RB, Wapenaar R, Wegner S, Gorecki P, Gramiccia T, Jazra M, Buyze J, Conrad C. Puig L, et al. Am J Clin Dermatol. 2024 Mar;25(2):315-325. doi: 10.1007/s40257-023-00816-1. Epub 2023 Oct 7. Am J Clin Dermatol. 2024. PMID: 37804472 Free PMC article.
106 results